{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:32:29Z","timestamp":1777923149454,"version":"3.51.4"},"reference-count":47,"publisher":"SAGE Publications","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Microbial Drug Resistance"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Extensive use of carbapenems to treat multidrug-resistant (MDR) Gram-negative bacteria (GNB) facilitates the wide dissemination of carbapenemase-producing carbapenem-resistant GNB. Colistin was reintroduced into clinical settings to manage these GNB infections. However, there is currently an increase in the dissemination of mobile colistin resistance (\n                      <jats:italic toggle=\"yes\">mcr)<\/jats:italic>\n                      -producing colistin-resistant GNB isolates in clinical settings. The epidemiology of carbapenemases and\n                      <jats:italic toggle=\"yes\">mcr<\/jats:italic>\n                      in Pretoria was evaluated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Clinical MDR GNB were collected and screened for carbapenemases and\n                      <jats:italic toggle=\"yes\">mcr<\/jats:italic>\n                      using polymerase chain reaction (PCR); their antibiotic susceptibility profiles were elucidated using the Vitek\n                      <jats:sup>\u00ae<\/jats:sup>\n                      2 automated system (Biomerieux, France) and microbroth dilution (for colistin).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results and Discussion:<\/jats:title>\n                    <jats:p>\n                      A total of 306 isolates were collected; a majority of these were\n                      <jats:italic toggle=\"yes\">Klebsiella pneumoniae<\/jats:italic>\n                      (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u2009208) and were collected from males (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u2009158). The isolates were retrieved from a variety of infection sites, including urine, blood cultures, and rectal swabs. The Vitek 2 system found that these isolates were largely resistant to \u03b2-lactams, where 217 (70.9%) had reduced susceptibility to at least one carbapenem (ertapenem, meropenem, or imipenem), and 81 isolates (26.5%) were resistant to colistin. PCR screening identified 201 (65.7%) isolates harboring carbapenemase genes consisting of\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>OXA-48<\/jats:sub>\n                      (170, 84.2%),\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>NDM<\/jats:sub>\n                      (31, 15.4%),\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>IMP<\/jats:sub>\n                      (5, 2%),\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>KPC<\/jats:sub>\n                      (4, 1%), and\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>VIM<\/jats:sub>\n                      (5, 2%). Furthermore, 14\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>OXA-48<\/jats:sub>\n                      \u2013producing isolates were coharboring\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>VIM<\/jats:sub>\n                      (2),\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>NDM<\/jats:sub>\n                      (9),\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>KPC<\/jats:sub>\n                      (1), and\n                      <jats:italic toggle=\"yes\">bla<\/jats:italic>\n                      <jats:sub>IMP<\/jats:sub>\n                      (2) genes. Only one isolate harbored the mobile colistin resistance (\n                      <jats:italic toggle=\"yes\">mcr<\/jats:italic>\n                      )\n                      <jats:italic toggle=\"yes\">-1<\/jats:italic>\n                      gene, and this is the first report of an\n                      <jats:italic toggle=\"yes\">mcr-1<\/jats:italic>\n                      \u2013producing\n                      <jats:italic toggle=\"yes\">Acinetobacter baumannii<\/jats:italic>\n                      isolate in South Africa.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      There is high endemicity of carbapenemase genes and a low prevalence of\n                      <jats:italic toggle=\"yes\">mcr<\/jats:italic>\n                      genes in GNB, particularly in\n                      <jats:italic toggle=\"yes\">K. pneumoniae,<\/jats:italic>\n                      in health care facilities in Pretoria and surrounding regions of South Africa.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Health care facilities in Pretoria are becoming breeding grounds for MDR infections that threaten public health. Careful use of carbapenems and other antibiotics is necessary to prevent further escalation and outbreak of these MDR strains that can claim several lives.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/mdr.2022.0112","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T14:32:02Z","timestamp":1666017122000},"page":"1028-1036","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":12,"title":["Molecular Screening of Clinical Multidrug-Resistant Gram-Negative Bacteria Shows Endemicity of Carbapenemases, Coexistence of Multiple Carbapenemases, and Rarity of\n                    <i>mcr<\/i>\n                    in South Africa"],"prefix":"10.1177","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5238-454X","authenticated-orcid":false,"given":"Masego","family":"Mmatli","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology, School of Medicine, University of Pretoria, Pretoria, South Africa."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tumisho Mmatumelo Seipei","family":"Leshaba","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, School of Medicine, University of Pretoria, Pretoria, South Africa."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lebogang B.","family":"Skosana","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, School of Medicine, University of Pretoria, Pretoria, South Africa."},{"name":"Tshwane Academic Division, Department of Medical Microbiology, National Health Laboratory Service, Pretoria, South Africa."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nontombi Marylucy","family":"Mbelle","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, School of Medicine, University of Pretoria, Pretoria, South Africa."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9508-984X","authenticated-orcid":false,"given":"John","family":"Osei Sekyere","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, School of Medicine, University of Pretoria, Pretoria, South Africa."},{"name":"Department of Dermatology, School of Medicine, University of Pretoria, Pretoria, South Africa."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2022,11,14]]},"reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"crossref","first-page":"8654","DOI":"10.3390\/ijms21228654","article-title":"New bacteriocins from Lacticaseibacillus paracasei CNCM I-5369 adsorbed on alginate nanoparticles are very active against Escherichia coli","volume":"21","author":"Belguesmia Y","year":"2022","unstructured":"Belguesmia Y, , Hazime N, , Kempf I, et al. New bacteriocins from Lacticaseibacillus paracasei CNCM I-5369 adsorbed on alginate nanoparticles are very active against Escherichia coli. Int J Mol Sci, 2022; 21:8654.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_6_3_2","first-page":"e02881","article-title":"Colistin heteroresistance is largely undetected among carbapenem-resistant enterobacterales in the United States","volume":"12","author":"Band VI","year":"2021","unstructured":"Band VI, , Satola SW, , Smith RD, et al. Colistin heteroresistance is largely undetected among carbapenem-resistant enterobacterales in the United States. Mbio, 2021; 12:e02881-02820; doi: 10.1128\/mBio.02881-20","journal-title":"Mbio"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.3573"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofv050"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00064-16"},{"issue":"4","key":"e_1_3_6_7_2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1556\/030.2020.01181","article-title":"et al. Detection of VIM, NDM and OXA-48 producing carbapenem resistant Enterobacterales among clinical isolates in Southern Hungary","volume":"67","author":"Gajd\u00e1cs M","year":"2020","unstructured":"Gajd\u00e1cs M, , \u00c1br\u00f3k M, , L\u00e1z\u00e1r A. et al. Detection of VIM, NDM and OXA-48 producing carbapenem resistant Enterobacterales among clinical isolates in Southern Hungary. Acta Microbiol Immunol Hung, 2020; 67(4):209\u2013215; doi: 10.1556\/030.2020.01181","journal-title":"Acta Microbiol Immunol Hung"},{"key":"e_1_3_6_8_2","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3390\/genes12070951","article-title":"Genomic investigation of carbapenem-resistant Klebsiella pneumonia colonization in an intensive care unit in South Africa","volume":"12","author":"Madni O","year":"2021","unstructured":"Madni O, , Amoako DG, , Abia ALK, et al. Genomic investigation of carbapenem-resistant Klebsiella pneumonia colonization in an intensive care unit in South Africa. Genes (Basel), 2021; 12:951; doi: 10.3390\/genes12070951","journal-title":"Genes (Basel)"},{"key":"e_1_3_6_9_2","first-page":"1","article-title":"Carbapenem resistance: A review","volume":"6","author":"Codjoe FS","year":"2018","unstructured":"Codjoe FS, , Donkor ES. Carbapenem resistance: A review. Med Sci, 2018; 6:1.","journal-title":"Med Sci"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/2049936115621709"},{"key":"e_1_3_6_11_2","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.2147\/IDR.S226416","article-title":"Molecular epidemiological insights into colistin-resistant and carbapenemases-producing clinical Klebsiella pneumoniae isolates","volume":"12","author":"Di Tella D","year":"2019","unstructured":"Di Tella D, , Tamburro M, , Guerrizio G. et al. Molecular epidemiological insights into colistin-resistant and carbapenemases-producing clinical Klebsiella pneumoniae isolates. Infect Drug Resist, 2019; 12:3783\u20133795; doi: 10.2147\/IDR.S226416","journal-title":"Infect Drug Resist"},{"key":"e_1_3_6_12_2","doi-asserted-by":"crossref","first-page":"e00783","DOI":"10.1128\/mSystems.00783-20","article-title":"emerging transcriptional and genomic mechanisms mediating carbapenem and polymyxin resistance in enterobacteriaceae: A systematic review of current reports","volume":"5","author":"Mmatli M","year":"2020","unstructured":"Mmatli M, , Mbelle NM, , Maningi NE, et al. emerging transcriptional and genomic mechanisms mediating carbapenem and polymyxin resistance in enterobacteriaceae: A systematic review of current reports. mSystems, 2020; 5:e00783-00720.","journal-title":"mSystems"},{"issue":"10","key":"e_1_3_6_13_2","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1128\/AAC.01019-15","article-title":"Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance","volume":"59","author":"Pitout JD","year":"2015","unstructured":"Pitout JD, , Nordmann P, , Poirel L. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother, 2015; 59(10):5873\u20135884; doi: 10.1128\/AAC.01019-15","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"e_1_3_6_14_2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.33073\/pjm-2019-055","article-title":"Colistin resistance in enterobacterales strains\u2014A current view","volume":"68","author":"Stefaniuk EM","year":"2019","unstructured":"Stefaniuk EM, , Tyski S. Colistin resistance in enterobacterales strains\u2014A current view. Pol J Microbiol, 2019; 68(4):417\u2013427; doi: 10.33073\/pjm-2019-055","journal-title":"Pol J Microbiol"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.1086\/592412"},{"issue":"7","key":"e_1_3_6_16_2","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s10096-020-03845-4","article-title":"Carbapenem-resistant enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018","volume":"39","author":"Perovic O","year":"2020","unstructured":"Perovic O, , Ismail H, , Quan V, et al. Carbapenem-resistant enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018. Eur J Clin Microbiol Infect Dis, 2020; 39(7):1287\u20131294; doi: 10.1007\/s10096-020-03845-4","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"e_1_3_6_17_2","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2147\/IDR.S250384","article-title":"et al. Analysis of susceptibilities of carbapenem resistant enterobacterales to colistin in intra-abdominal, respiratory and urinary tract infections from 2015 to 2017","volume":"13","author":"Zhang H","year":"2020","unstructured":"Zhang H, , Zhang J, , Kang Y. et al. Analysis of susceptibilities of carbapenem resistant enterobacterales to colistin in intra-abdominal, respiratory and urinary tract infections from 2015 to 2017. Infect Drug Resist, 2020; 13:1937\u20131948; doi: 10.2147\/IDR.S250384","journal-title":"Infect Drug Resist"},{"key":"e_1_3_6_18_2","unstructured":"World Health Organization. Critically important antimicrobials for human medicine: ranking of antimicrobial agents for risk management of antimicrobial resistance due to non-human use. Report No. 9789241512220 2017. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/255027 [Last accessed: September26 2022]."},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2014.00643"},{"key":"e_1_3_6_20_2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/microorganisms8010137","article-title":"Genomic analysis of carbapenemase-producing extensively drug-resistant Klebsiella pneumoniae isolates reveals the horizontal spread of p18\u201343_01 plasmid encoding blaNDM-1 in South Africa","volume":"8","author":"Ramsamy Y","year":"2020","unstructured":"Ramsamy Y, , Mlisana K P, , Allam M, et al. Genomic analysis of carbapenemase-producing extensively drug-resistant Klebsiella pneumoniae isolates reveals the horizontal spread of p18\u201343_01 plasmid encoding blaNDM-1 in South Africa. Microorganisms, 2020; 8:137.","journal-title":"Microorganisms"},{"issue":"6","key":"e_1_3_6_21_2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ijantimicag.2016.06.023","article-title":"Molecular mechanisms of polymyxin resistance: Knowns and unknowns","volume":"48","author":"Baron S","year":"2016","unstructured":"Baron S, , Hadjadj L, , Rolain J-M, et al. Molecular mechanisms of polymyxin resistance: Knowns and unknowns. Int J Antimicrob Agents, 2016; 48(6):583\u2013591; doi: 10.1016\/j.ijantimicag.2016.06.023","journal-title":"Int J Antimicrob Agents"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00424-7"},{"key":"e_1_3_6_23_2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijid.2019.11.021","article-title":"et al. Clonal expansion of colistin-resistant Acinetobacter baumannii isolates in Cape Town, South Africa","volume":"91","author":"Snyman Y","year":"2020","unstructured":"Snyman Y, , Whitelaw AC, , Reuter S. et al. Clonal expansion of colistin-resistant Acinetobacter baumannii isolates in Cape Town, South Africa. Int J Infect Dis, 2020; 91:94\u2013100; doi: 10.1016\/j.ijid.2019.11.021","journal-title":"Int J Infect Dis"},{"issue":"7","key":"e_1_3_6_24_2","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1128\/AAC.00444-16","article-title":"et al. Genetic features of MCR-1-producing colistin-resistant Escherichia coli isolates in South Africa","volume":"60","author":"Poirel L","year":"2016","unstructured":"Poirel L, , Kieffer N, , Brink A. et al. Genetic features of MCR-1-producing colistin-resistant Escherichia coli isolates in South Africa. Antimicrob Agents Chemother, 2016; 60(7):4394\u20134397; doi: 10.1128\/AAC.00444-16","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_3_6_25_2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13756-017-0234-8","article-title":"Plasmid-mediated mcr-1 colistin resistance in Escherichia coli and Klebsiella spp. clinical isolates from the Western Cape region of South Africa","volume":"6","author":"Newton-Foot M","year":"2017","unstructured":"Newton-Foot M, , Snyman Y, , Maloba MRB, et al. Plasmid-mediated mcr-1 colistin resistance in Escherichia coli and Klebsiella spp. clinical isolates from the Western Cape region of South Africa. Antimicrob Resist Infect Control, 2017; 6:78; doi: 10.1186\/s13756-017-0234-8","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"e_1_3_6_26_2","first-page":"1962781","article-title":"Is Africa ready for mobile colistin resistance threat?","volume":"11","author":"Anyanwu MU","year":"2021","unstructured":"Anyanwu MU, , Jaja IF, , Oguttu JW, et al. Is Africa ready for mobile colistin resistance threat?. Infect Ecol Epidemiol, 2021; 11(1):1962781; doi: 10.1080\/20008686.2021.1962781","journal-title":"Infect Ecol Epidemiol"},{"key":"e_1_3_6_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.14223"},{"issue":"3","key":"e_1_3_6_28_2","doi-asserted-by":"crossref","first-page":"150641","DOI":"10.1016\/j.scitotenv.2021.150641","article-title":"Mobile genetic elements-mediated Enterobacterales-associated carbapenemase antibiotic resistance genes propagation between the environment and humans: A One Health South African study","volume":"806","author":"Ramsamy Y","year":"2022","unstructured":"Ramsamy Y, , Mlisana KP, , Amoako DG, et al. Mobile genetic elements-mediated Enterobacterales-associated carbapenemase antibiotic resistance genes propagation between the environment and humans: A One Health South African study. Sci Total Environ, 2022; 806(Pt 3):150641; doi: 10.1016\/j.scitotenv.2021.150641","journal-title":"Sci Total Environ"},{"issue":"5","key":"e_1_3_6_29_2","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1469-0691.2012.03815.x","article-title":"Identification and screening of carbapenemase-producing enterobacteriaceae","volume":"18","author":"Nordmann P","year":"2012","unstructured":"Nordmann P, , Gniadkowski M, , Giske C. et al. Identification and screening of carbapenemase-producing enterobacteriaceae. Clin Microbiol Infect, 2012; 18(5):432\u2013438; doi: 10.1111\/j.1469-0691.2012.03815.x","journal-title":"Clin Microbiol Infect"},{"key":"e_1_3_6_30_2","unstructured":"Testing E C o A S. Recommendations for MIC Determination of Colistin (Polymyxin E) as Recommended by the Joint CLSI-EUCAST Polymyxin Breakpoints Working Group. EUCAST: V\u00e4xj\u00f6 Sweden; 2016."},{"key":"e_1_3_6_31_2","unstructured":"Govender K. Detection of carbapenem-resistant enterobacteriaceae amongst neonates in a regional hospital in KwaZulu-Natal: screening for carbapenemase production and MIC correlation. PhD thesis. University of KwaZulu-Natal; 2014."},{"issue":"1","key":"e_1_3_6_32_2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/nyas.14650","article-title":"Risk factors for, and molecular epidemiology and clinical outcomes of, carbapenem- and polymyxin-resistant Gram-negative bacterial infections in pregnant women, infants, and toddlers: A systematic review and meta-analyses","volume":"1502","author":"Osei Sekyere J","year":"2021","unstructured":"Osei Sekyere J, , Reta MA, , Bernard Fourie P. Risk factors for, and molecular epidemiology and clinical outcomes of, carbapenem- and polymyxin-resistant Gram-negative bacterial infections in pregnant women, infants, and toddlers: A systematic review and meta-analyses. Ann N Y Acad Sci, 2021; 1502(1):54\u201371; doi: 10.1111\/nyas.14650","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"e_1_3_6_33_2","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7196\/SAMJ.2016.v106i10.11300","article-title":"Molecular detection of carbapenemase-producing genes in referral enterobacteriaceae in South Africa: A short report","volume":"106","author":"Perovic O","year":"2016","unstructured":"Perovic O, , Britz E, , Chetty V, et al. Molecular detection of carbapenemase-producing genes in referral enterobacteriaceae in South Africa: A short report. S Afr Med J, 2016; 106(10):975\u2013977; doi: 10.7196\/SAMJ.2016.v106i10.11300","journal-title":"S Afr Med J"},{"issue":"1","key":"e_1_3_6_34_2","first-page":"129","article-title":"Carbapenemase-producing enterobacteriaceae colonisation in adult inpatients: A point prevalence study","volume":"34","author":"Nel P","year":"2019","unstructured":"Nel P, , Roberts LA, , Hoffmann R. Carbapenemase-producing enterobacteriaceae colonisation in adult inpatients: A point prevalence study. S Afr J Infect Dis, 2019; 34(1):129; doi: 10.4102\/sajid.v34i1.129","journal-title":"S Afr J Infect Dis"},{"issue":"12","key":"e_1_3_6_35_2","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.7196\/SAMJ.2015.v105i12.9926","article-title":"et al. Molecular characterisation and epidemiological investigation of an outbreak of blaOXA-181 carbapenemaseproducing isolates of Klebsiella pneumoniae in South Africa","volume":"105","author":"Jacobson RK","year":"2015","unstructured":"Jacobson RK, , Manesen MR, , Moodley C. et al. Molecular characterisation and epidemiological investigation of an outbreak of blaOXA-181 carbapenemaseproducing isolates of Klebsiella pneumoniae in South Africa. S Afr Med J, 2015; 105(12):1030\u20131035; doi: 10.7196\/SAMJ.2015.v105i12.9926","journal-title":"S Afr Med J"},{"issue":"8","key":"e_1_3_6_36_2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.7196\/SAMJ.2020.v110i8.14471","article-title":"A multisectoral investigation of a neonatal unit outbreak of Klebsiella pneumoniae bacteraemia at a regional hospital in Gauteng Province, South Africa","volume":"110","author":"Essel V","year":"2020","unstructured":"Essel V, , Tshabalala K, , Ntshoe G, et al. A multisectoral investigation of a neonatal unit outbreak of Klebsiella pneumoniae bacteraemia at a regional hospital in Gauteng Province, South Africa. S Afr Med J, 2020; 110(8):783\u2013790; doi: 10.7196\/SAMJ.2020.v110i8.14471","journal-title":"S Afr Med J"},{"key":"e_1_3_6_37_2","first-page":"1","article-title":"Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae","volume":"16","author":"Xu L","year":"2017","unstructured":"Xu L, , Sun X, Ma X. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob, 2017; 16; 1\u201312.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"e_1_3_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30753-3"},{"issue":"1","key":"e_1_3_6_39_2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12879-017-2383-z","article-title":"Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with enterobacteriaceae urinary tract infection, pneumonia and sepsis","volume":"17","author":"Zilberberg MD","year":"2017","unstructured":"Zilberberg MD, , Nathanson BH, , Sulham K, et al. Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with enterobacteriaceae urinary tract infection, pneumonia and sepsis. BMC Infect Dis, 2017; 17(1):279; doi: 10.1186\/s12879-017-2383-z","journal-title":"BMC Infect Dis"},{"issue":"1","key":"e_1_3_6_40_2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/1120009X.2017.1380395","article-title":"Multi-drug-resistant Gram-negative bacteria causing urinary tract infections: A review","volume":"29","author":"Mazzariol A","year":"2017","unstructured":"Mazzariol A, , Bazaj A, , Cornaglia G. Multi-drug-resistant Gram-negative bacteria causing urinary tract infections: A review. J Chemother, 2017; 29(Suppl. 1):2\u20139; doi: 10.1080\/1120009X.2017.1380395","journal-title":"J Chemother"},{"issue":"5","key":"e_1_3_6_41_2","doi-asserted-by":"crossref","first-page":"03","DOI":"10.1128\/microbiolspec.UTI-0002-2012","article-title":"Clinical presentations and epidemiology of urinary tract infections","volume":"4","author":"Geerlings SE","year":"2016","unstructured":"Geerlings SE. Clinical presentations and epidemiology of urinary tract infections. Microbiol Spectr, 2016; 4(5):03; doi: 10.1128\/microbiolspec.UTI-0002-2012","journal-title":"Microbiol Spectr"},{"key":"e_1_3_6_42_2","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.3390\/microorganisms8111716","article-title":"Colistin update on its mechanism of action and resistance, present and future challenges","volume":"8","author":"Andrade FF","year":"2020","unstructured":"Andrade FF, , Silva D, , Rodrigues A, et al. Colistin update on its mechanism of action and resistance, present and future challenges. Microorganisms, 2020; 8:1716.","journal-title":"Microorganisms"},{"key":"e_1_3_6_43_2","doi-asserted-by":"crossref","first-page":"677720","DOI":"10.3389\/fmed.2021.677720","article-title":"et al. Current update on intrinsic and acquired colistin resistance mechanisms in bacteria","volume":"8","author":"Gogry FA","year":"2021","unstructured":"Gogry FA, , Siddiqui MT, , Sultan I. et al. Current update on intrinsic and acquired colistin resistance mechanisms in bacteria. Front Med (Lausanne), 2021; 8:677720; doi: 10.3389\/fmed.2021.677720","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"e_1_3_6_44_2","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1128\/AAC.00284-09","article-title":"et al. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system","volume":"53","author":"Adams MD","year":"2009","unstructured":"Adams MD, , Nickel GC, , Bajaksouzian S. et al. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob Agents Chemother, 2009; 53(9):3628\u20133634; doi: 10.1128\/AAC.00284-09","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_3_6_45_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2019.0085"},{"issue":"6","key":"e_1_3_6_46_2","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.ijantimicag.2018.03.020","article-title":"et al. Role of association of OmpK35 and OmpK36 alteration and blaESBL and\/or blaAmpC genes in conferring carbapenem resistance among non-carbapenemase-producing Klebsiella pneumoniae","volume":"52","author":"Hamzaoui Z","year":"2018","unstructured":"Hamzaoui Z, , Ocampo-Sosa A, , Fernandez Martinez M. et al. Role of association of OmpK35 and OmpK36 alteration and blaESBL and\/or blaAmpC genes in conferring carbapenem resistance among non-carbapenemase-producing Klebsiella pneumoniae. Int J Antimicrob Agents, 2018; 52(6):898\u2013905; doi: 10.1016\/j.ijantimicag.2018.03.020","journal-title":"Int J Antimicrob Agents"},{"key":"e_1_3_6_47_2","first-page":"435","article-title":"Present and future of carbapenem-resistant enterobacteriaceae (CRE) infections","volume":"8","author":"Suay-Garc\u00eda B","year":"2019","unstructured":"Suay-Garc\u00eda B, , P\u00e9rez-Gracia MT. Present and future of carbapenem-resistant enterobacteriaceae (CRE) infections. Antibiotics (Basel), 2019; 8:435\u2013456; doi: 10.3390\/antibiotics8030122","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"e_1_3_6_48_2","first-page":"241","article-title":"Carriage of colistin-resistant Gram-negative bacteria in children from communities in Cape Town (Tuberculosis child multidrug-resistant preventive therapy trial sub-study)","volume":"36","author":"Snyman Y","year":"2021","unstructured":"Snyman Y, , Whitelaw AC, , Maloba MRB, et al. Carriage of colistin-resistant Gram-negative bacteria in children from communities in Cape Town (Tuberculosis child multidrug-resistant preventive therapy trial sub-study). S Afr J Infect Dis, 2021; 36(1):241; doi: 10.4102\/sajid.v36i1.241","journal-title":"S Afr J Infect Dis"}],"container-title":["Microbial Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/mdr.2022.0112","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2022.0112","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2022.0112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:40:26Z","timestamp":1777668026000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/mdr.2022.0112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["10.1089\/mdr.2022.0112"],"URL":"https:\/\/doi.org\/10.1089\/mdr.2022.0112","relation":{},"ISSN":["1076-6294","1931-8448"],"issn-type":[{"value":"1076-6294","type":"print"},{"value":"1931-8448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11]]}}}